- Home
- ARWR vs GBCI Comparison
ARWR vs GBCI Comparison
Compare ARWR & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | GBCI |
|---|---|---|
| Founded | 2003 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.7B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | GBCI |
|---|---|---|
| Price | $70.94 | $44.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $60.70 | $51.80 |
| AVG Volume (30 Days) | ★ 3.3M | 680.6K |
| Earning Date | 11-25-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | N/A | ★ 26.70 |
| EPS | N/A | ★ 2.05 |
| Revenue | $829,448,000.00 | ★ $900,148,000.00 |
| Revenue This Year | N/A | $13.46 |
| Revenue Next Year | N/A | $27.84 |
| P/E Ratio | ★ N/A | $21.63 |
| Revenue Growth | ★ 23258.15 | 15.35 |
| 52 Week Low | $9.57 | $36.76 |
| 52 Week High | $72.36 | $57.22 |
Technical Indicators
Market Signals| Indicator | ARWR | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 78.58 | 59.97 |
| Support Level | $60.29 | $42.09 |
| Resistance Level | $71.50 | $43.49 |
| Average True Range (ATR) | 5.14 | 1.10 |
| MACD | 1.73 | 0.34 |
| Stochastic Oscillator | 95.82 | 97.39 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About GBCI Glacier Bancorp Inc.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.